Science-in-brief: The importance of senescence in tendinopathy: New opportunities.

1. Smith RK, Birch HL, Goodman S, Heinegard D, Goodship AE. The influence of ageing and exercise on tendon growth and degeneration-hypotheses for the initiation and prevention of strain-induced tendinopathies.. Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 2002 133, 1039-1050.
2. Peffers MJ, Thorpe CT, Collins JA, Eong R, Wei TK, Screen HR, Clegg PD. Proteomic analysis reveals age-related changes in tendon matrix composition, with age- and injury-specific matrix fragmentation.. J. Biol. Chem. 2014 289, 25867-25878.
3. Smith RK, Birch H, Patterson-Kane J, Firth EC, Williams L, Cherdchutham W, van Weeren WR, Goodship AE. Should equine athletes commence training during skeletal development?: changes in tendon matrix associated with development, ageing, function and exercise.. Equine Vet. J. 1999 31, Suppl. 30, 201-219.
4. Dyson SJ. Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992-2000).. Equine Vet. J. 2004 36, 415-419.
5. Dudhia J, Scott CM, Draper ERC, Heinegard D, Pitsillides AA, Smith RK. Aging enhances a mechanically-induced reduction in tendon strength by an active process involving matrix metalloproteinase activity.. Aging Cell. 2007 6, 547-556.
6. Dakin SG, Dudhia J, Smith RK. Resolving an inflammatory concept: the importance of inflammation and resolution in tendinopathy.. Vet. Immunol. Immunopathol. 2014 158, 121-127.
7. Clegg PD, Strassburg S, Smith RK. Cell phenotypic variation in normal and damaged tendons.. Int. J. Exp. Pathol. 2007 88, 227-235.
8. Hosaka Y, Kirisawa R, Yamamoto E, Ueda H, Iwai H, Takehana K. Localization of cytokines in tendinocytes of the superficial digital flexor tendon in the horse.. J. Vet. Med. Sci. 2002 64, 945-947.
9. Faragher RG, McArdle A, Willows A, Ostler EL. Senescence in the aging process.. F1000Res. 2017 6, 1219.
10. Poulsen RC, Watts AC, Murphy RJ, Snelling SJ, Carr AJ, Hulley PA. Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence.. Ann. Rheum. Dis. 2014 73, 1405-1413.
11. Argyle D, Ellsmore V, Gault EA, Munro AF, Nasir L. Equine telomeres and telomerase in cellular immortalisation and ageing.. Mech. Ageing Dev. 2003 124, 759-764.
12. Vidale P, Magnani E, Nergadze SG, Santagostino M, Cristofari G, Smirnova A, Mondello C, Giulotto E. The catalytic and the RNA subunits of human telomerase are required to immortalize equid primary fibroblasts.. Chromosoma. 2012 121, 475-488.
13. Demaria M, O'Leary MN, Chang J, Shao L, Liu S, Alimirah F, Koenig K, Le C, Mitin N, Deal AM, Alston S, Academia EC, Kilmarx S, Valdovinos A, Wang B, de Bruin A, Kennedy BK, Melov S, Zhou D, Sharpless NE, Muss H, Campisi J. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse.. Cancer Discov. 2016 7, 165-176.
14. Burton DG, Faragher RG. Cellular senescence: from growth arrest to immunogenic conversion.. Age (Dordr.). 2015 37, 27-46.
15. He S, Sharpless NE. Senescence in health and disease.. Cell. 2017 169, 1000-1011.
16. Demaria M, Ohtani N, Youssef SA, Rodier F, Toussaint W, Mitchell JR, Laberge RM, Vijg J, Van Steeg H, Dollé ME, Hoeijmakers JH, de Bruin A, Hara E, Campisi J. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA.. Dev. Cell. 2014 31, 722-733.
17. Ovadya Y, Landsberger T, Leins H, Vadai E, Gal H, Biran A, Yosef R, Sagiv A, Agrawal A, Shapira A, Windheim J, Tsoory M, Schirmbeck R, Amit I, Geiger H, Krizhanovsky V. Impaired immune surveillance accelerates accumulation of senescent cells and aging.. Nat. Commun. 2018 9, 5435.
18. Kohler J, Popov C, Klotz B, Alberton P, Prall WC, Haasters F, Müller-Deubert S, Ebert R, Klein-Hitpass L, Jakob F, Schieker M, Docheva D. Uncovering the cellular and molecular changes in tendon stem/progenitor cells attributed to tendon aging and degeneration.. Aging Cell. 2013 12, 988-999.
19. Nichols AEC, Settlage RE, Werre SR, Dahlgren LA. Novel roles for scleraxis in regulating adult tenocyte function.. BMC Cell Biol. 2018 19, 14.
20. Spang C, Chen J, Backman LJ. The tenocyte phenotype of human primary tendon cells in vitro is reduced by glucocorticoids.. BMC Musculoskelet Disord. 2016 17, 467.
21. Torricelli P, Fini M, Giavaresi G, Carpi A, Nicolini A, Giardino R. Effects of systemic glucocorticoid administration on tenocytes.. Biomed. Pharmacother. 2006 60, 380-385.
22. Flaherty RL, Owen M, Fagan-Murphy A, Intabli H, Healy D, Patel A, Allen MC, Patel BA, Flint MS. Glucocorticoids induce production of reactive oxygen species/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer.. Breast Cancer Res. 2017 19, 35.
23. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders.. Nature. 2011 479, 232-236.
24. Baker DJ, Childs BG, Durik M, Wijers ME, Sieben CJ, Zhong J, Saltness RA, Jeganathan KB, Verzosa GC, Pezeshki A, Khazaie K, Miller JD, van Deursen JM. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan.. Nature. 2016 530, 184-189.
25. Malavolta M, Pierpaoli E, Giacconi R, Costarelli L, Piacenza F, Basso A, Cardelli M, Provinciali M. Pleiotropic effects of tocotrienols and quercetin on cellular senescence: introducing the perspective of senolytic effects of phytochemicals.. Curr. Drug Targets. 2016 17, 447-459.
26. Zhu Y, Tchkonia T, Fuhrmann-Stroissnigg H, Dai HM, Ling YY, Stout MB, Pirtskhalava T, Giorgadze N, Johnson KO, Giles CB, Wren JD, Niedernhofer LJ, Robbins PD, Kirkland JL. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.. Aging Cell. 2016 15, 428-435.
27. Watts AE, Dabareiner R, Marsh C, Carter GK, Cummings KJ. A randomized, controlled trial of the effects of resveratrol administration in performance horses with lameness localized to the distal tarsal joints.. J. Am. Vet. Med. Ass. 2016 249, 650-659.
28. Zhu Y, Tchkonia T, Pirtskhalava T, Gower AC, Ding H, Giorgadze N, Palmer AK, Ikeno Y, Hubbard GB, Lenburg M, O'Hara SP, LaRusso NF, Miller JD, Roos CM, Verzosa GC, LeBrasseur NK, Wren JD, Farr JN, Khosla S, Stout MB, McGowan SJ, Fuhrmann-Stroissnigg H, Gurkar AU, Zhao J, Colangelo D, Dorronsoro A, Ling YY, Barghouthy AS, Navarro DC, Sano T, Robbins PD, Niedernhofer LJ, Kirkland JL. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.. Aging Cell. 2015 14, 644-658.
29. Justice JN, Nambiar AM, Tchkonia T, LeBrasseur NK, Pascual R, Hashmi SK, Prata L, Masternak MM, Kritchevsky SB, Musi N, Kirkland JL. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study.. EBioMedicine. 2019 40, 554-563.
30. Zaseck LW, Miller RA, Brooks SV. Rapamycin attenuates age-associated changes in tibialis anterior tendon viscoelastic properties.. J. Gerontol. A Biol. Sci. Med. Sci. 2016 71, 858-865.
31. Herranz N, Gallage S, Mellone M, Wuestefeld T, Klotz S, Hanley CJ, Raguz S, Acosta JC, Innes AJ, Banito A, Georgilis A, Montoya A, Wolter K, Dharmalingam G, Faull P, Carroll T, Martínez-Barbera JP, Cutillas P, Reisinger F, Heikenwalder M, Miller RA, Withers D, Zender L, Thomas GJ, Gil J. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype.. Nat. Cell Biol. 2015 17, 1205-1217.

Citations

1. Xu K, Lin C, Ma D, Chen M, Zhou X, He Y, Moqbel SAA, Ma C, Wu L. Spironolactone Ameliorates Senescence and Calcification by Modulating Autophagy in Rat Tendon-Derived Stem Cells via the NF-κB/MAPK Pathway.. Oxid Med Cell Longev 2021;2021:5519587.
   doi: 10.1155/2021/5519587pubmed: 34306308google scholar: lookup